The long-term effect of biologics in patients with ulcerative colitis emerging from a large Japanese cohortULCERATIVE colitisINFLAMMATORY bowel diseasesBIOLOGICALSSURGICAL excisionREGRESSION analysisDEEP brain stimulationDISEASE exacerbationTo gain abetter understanding of the effects of biologics, we evaluated ...
Ulcerative colitis is characterized by chronic inflammation of the colon. Typical symptoms are diarrhoea, rectal bleeding, abdominal pain and fever. The aetiology of the disease is unclear. The inflammation can be localized in the rectum or can extend to the left side or the whole colon. Treatmen...
The present study evaluates the long-term (2 years) effects of combination therapy (mesalazine plus a probiotic blend of Lactobacillus salivarius, Lactobacillus acidophilus and Bifidobacterium bifidus strain BGN4) on ulcerative colitis activity.Method: Sixty patients with moderate-to-severe ulcerative ...
Ulcerative Colitis Prognosis For most people, ulcerative colitis is a chronic, or long-term, condition. You’ll have flares and periods with no symptoms at all (your doctor will call this remission). A small number of people have one attack and are never troubled again. ...
Ulcerative colitis(UC) is a long-term disease, but it's possible to take charge of it and live well. Your doctor will work with you to find a treatment that controls your symptoms and helps keep them from coming back. When you go a while without symptoms, that's called remission. When...
In ulcerative colitis (UC), histological remission may predict long-term outcomes, including corticosteroid use and hospitalization, better than endoscopy, according to a recent studypublished onlineMay 18 inGut. The study is the first to systematically evaluate how well histologic remission predicts lon...
bring the disorder under control. Then the drug is tapered down and then usually stopped. These medications are given by pill, enema or intravenously during an acute attack. In time, the physician will usually try to discontinue these drugs because of potential long-term, adverse side effects....
To study the long-term effects of restorative proctocolectomy with J-pouch for ulcerative colitis 100 consecutive patients were examined a mean of 5.6 years after ileal pouch-anal anastomosis (IPAA). Seventythree percent of patients were on steroids and 22% had a preceding severe attack of colit...
OBJECTIVE: This study describes long-term adjustment of people with a continent ileostomy. SUBJECTS AND METHODS: Subjects were 68 people (25 males and 43 females) who underwent an operation for ulcerative colitis with a continent ileosto... I Berndtsson,E Lindholm,I Ekman - 《J Wound Ostomy ...
Targeting the interlieukin-23 pathway with mirikizumab, a p19-directed IL-23 antibody, may be an effective option for maintenance therapy in ulcerative colitis, according to research presented at the Congress of the European Crohn&rsq...